Cancer Research CR Helping Patients  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vail, M. E.
Right arrow Articles by Fausto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vail, M. E.
Right arrow Articles by Fausto, N.
[Cancer Research 61, 594-601, January 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Bcl-2 Delays and Alters Hepatic Carcinogenesis Induced by Transforming Growth Factor {alpha}1

Mary E. Vail, Robert H. Pierce and Nelson Fausto2

Departments of Pathology [N. F.] and Molecular and Cellular Biology Program [M. E. V.], University of Washington, Seattle, Washington 98195-7610, and Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642 [R. H. P.]

Transgenic mice that overexpress transforming growth factor (TGF)-{alpha} develop liver tumors between 12 and 15 months of age. Tumor development is preceded by an overall increase in the rates of hepatocyte proliferation and cell death. To examine the role of apoptosis in the development of TGF-{alpha}-induced liver tumors, we generated TGF-{alpha}/Bcl-2 double transgenic mice by crossing TGF-{alpha} transgenic mice with Bcl-2 transgenic mice expressing a zinc-inducible Bcl-2 transgene. Overexpression of the Bcl-2 transgene protected hepatocytes from Fas-mediated apoptosis. We anticipated that hepatocytes in TGF-{alpha}/Bcl-2 double transgenic mice would be stimulated to proliferate but would fail to undergo apoptosis, leading to increased liver weights and accelerated tumorigenesis. At 4 weeks of age, both TGF-{alpha} single transgenic and TGF-{alpha}/Bcl-2 double transgenic mice had elevated hepatocyte proliferation and increased liver:body weight ratios. However, by 8 months, the liver:body weight ratios had normalized in both TGF-{alpha} single transgenic and TGF-{alpha}/Bcl-2 double transgenic mice. Furthermore, Bcl-2 functioned as a tumor suppressor, significantly decreasing the frequency and delaying the development of TGF-{alpha}-induced liver tumors, despite having comparable levels of TGF-{alpha} transgene expression in both single and double transgenic mice. Between 11 and 12 months of age, >80% of the TGF-{alpha} single transgenic mice had developed tumors, whereas only 54% of the double transgenic mice had developed tumors after 13 months of age. The tumors that eventually developed in the TGF-{alpha}/Bcl-2 double transgenic mice were histologically distinct and smaller in size and had lower hepatocyte mitotic activity than tumors from TGF-{alpha} single transgenic mice. Furthermore, delaying Bcl-2 expression until 8.5 months of age was sufficient to inhibit TGF-{alpha}-induced tumorigenesis. These results indicate that Bcl-2 inhibits tumor progression in the liver, possibly by interfering with hepatocyte proliferation.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Janumyan, Q. Cui, L. Yan, C. G. Sansam, M. Valentin, and E. Yang
G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation
J. Biol. Chem., December 5, 2008; 283(49): 34108 - 34120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Bailly-Maitre, E. Bard-Chapeau, F. Luciano, N. Droin, J.-M. Bruey, B. Faustin, C. Kress, J. M. Zapata, and J. C. Reed
Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration
Cancer Res., February 15, 2007; 67(4): 1442 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Bai, H.-M. Ni, X. Chen, D. DiFrancesca, and X.-M. Yin
Deletion of Bid Impedes Cell Proliferation and Hepatic Carcinogenesis
Am. J. Pathol., May 1, 2005; 166(5): 1523 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. H. Pierce, M. E. Vail, L. Ralph, J. S. Campbell, and N. Fausto
Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci
Am. J. Pathol., May 1, 2002; 160(5): 1555 - 1560.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Mitchell, V. O. Mallet, J. E. Guidotti, C. Goulenok, A. Kahn, and H. Gilgenkrantz
Liver Repopulation by Bcl-xL Transgenic Hepatocytes
Am. J. Pathol., January 1, 2002; 160(1): 31 - 35.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.